| Daniel J Margo, MD | |
|
1542 Golf Course Rd, Grand Rapids, MN 55744-9603 | |
| (218) 327-7973 | |
| (218) 327-3245 |
| Full Name | Daniel J Margo |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 34 Years |
| Location | 1542 Golf Course Rd, Grand Rapids, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083727200 | NPI | - | NPPES |
| 274517800 | Medicaid | MN | |
| 97B19MA | Other | MN | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 39379 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rainy Lake Medical Center | International falls, MN | Hospital |
| Bigfork Valley Hospital | Bigfork, MN | Hospital |
| Entity Name | Lakewood Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972799237 PECOS PAC ID: 5698687929 Enrollment ID: O20031104000469 |
News Archive
A new drug targeting the PI3K gene in patients with advanced breast cancer shows promising results in an early phase I investigational study conducted at Virginia G. Piper Cancer at Scottsdale Healthcare, according to a presentation by oncologist Dr. Daniel D. Von Hoff at the 47th annual meeting of the American Society of Clinical Oncology.
Scientists have made an important discovery that could lead to new drugs that reduce the severity of blood infections leading to sepsis. Research presented in the August 2010 issue of Journal of Leukocyte Biology shows how interfering with the function of the cell membrane protein called "Programmed Death 1" (PD-1) improves survival in a clinically relevant model of severe infection.
Small molecules found in fecal matter could provide clues to the early inflammation found in chronic gut conditions, such as intestinal bowel disease, and serve as new biomarkers for diagnosis, according to a study led by the Institute for Biomedical Sciences at Georgia State University.
"A critical loophole in the current version of the Senate health-care bill would allow insurers to charge more for those who don't participate in wellness programs, essentially negating the measure's key goal of eliminating higher costs for those with pre-existing conditions, a group of health experts said Thursday," MarketWatch reports.
Moffitt researchers David Basanta, PhD, and Conor Lynch, PhD, have been awarded a U01 grant to investigate prostate cancer metastasis.
› Verified 7 days ago
| Entity Name | International Falls Memorial Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528041183 PECOS PAC ID: 1951365998 Enrollment ID: O20041118000626 |
News Archive
A new drug targeting the PI3K gene in patients with advanced breast cancer shows promising results in an early phase I investigational study conducted at Virginia G. Piper Cancer at Scottsdale Healthcare, according to a presentation by oncologist Dr. Daniel D. Von Hoff at the 47th annual meeting of the American Society of Clinical Oncology.
Scientists have made an important discovery that could lead to new drugs that reduce the severity of blood infections leading to sepsis. Research presented in the August 2010 issue of Journal of Leukocyte Biology shows how interfering with the function of the cell membrane protein called "Programmed Death 1" (PD-1) improves survival in a clinically relevant model of severe infection.
Small molecules found in fecal matter could provide clues to the early inflammation found in chronic gut conditions, such as intestinal bowel disease, and serve as new biomarkers for diagnosis, according to a study led by the Institute for Biomedical Sciences at Georgia State University.
"A critical loophole in the current version of the Senate health-care bill would allow insurers to charge more for those who don't participate in wellness programs, essentially negating the measure's key goal of eliminating higher costs for those with pre-existing conditions, a group of health experts said Thursday," MarketWatch reports.
Moffitt researchers David Basanta, PhD, and Conor Lynch, PhD, have been awarded a U01 grant to investigate prostate cancer metastasis.
› Verified 7 days ago
| Entity Name | Itasca Surgical Clinic, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245288984 PECOS PAC ID: 7012925886 Enrollment ID: O20060405000375 |
News Archive
A new drug targeting the PI3K gene in patients with advanced breast cancer shows promising results in an early phase I investigational study conducted at Virginia G. Piper Cancer at Scottsdale Healthcare, according to a presentation by oncologist Dr. Daniel D. Von Hoff at the 47th annual meeting of the American Society of Clinical Oncology.
Scientists have made an important discovery that could lead to new drugs that reduce the severity of blood infections leading to sepsis. Research presented in the August 2010 issue of Journal of Leukocyte Biology shows how interfering with the function of the cell membrane protein called "Programmed Death 1" (PD-1) improves survival in a clinically relevant model of severe infection.
Small molecules found in fecal matter could provide clues to the early inflammation found in chronic gut conditions, such as intestinal bowel disease, and serve as new biomarkers for diagnosis, according to a study led by the Institute for Biomedical Sciences at Georgia State University.
"A critical loophole in the current version of the Senate health-care bill would allow insurers to charge more for those who don't participate in wellness programs, essentially negating the measure's key goal of eliminating higher costs for those with pre-existing conditions, a group of health experts said Thursday," MarketWatch reports.
Moffitt researchers David Basanta, PhD, and Conor Lynch, PhD, have been awarded a U01 grant to investigate prostate cancer metastasis.
› Verified 7 days ago
| Entity Name | Northern Itasca Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851335525 PECOS PAC ID: 3274442173 Enrollment ID: O20060911000628 |
News Archive
A new drug targeting the PI3K gene in patients with advanced breast cancer shows promising results in an early phase I investigational study conducted at Virginia G. Piper Cancer at Scottsdale Healthcare, according to a presentation by oncologist Dr. Daniel D. Von Hoff at the 47th annual meeting of the American Society of Clinical Oncology.
Scientists have made an important discovery that could lead to new drugs that reduce the severity of blood infections leading to sepsis. Research presented in the August 2010 issue of Journal of Leukocyte Biology shows how interfering with the function of the cell membrane protein called "Programmed Death 1" (PD-1) improves survival in a clinically relevant model of severe infection.
Small molecules found in fecal matter could provide clues to the early inflammation found in chronic gut conditions, such as intestinal bowel disease, and serve as new biomarkers for diagnosis, according to a study led by the Institute for Biomedical Sciences at Georgia State University.
"A critical loophole in the current version of the Senate health-care bill would allow insurers to charge more for those who don't participate in wellness programs, essentially negating the measure's key goal of eliminating higher costs for those with pre-existing conditions, a group of health experts said Thursday," MarketWatch reports.
Moffitt researchers David Basanta, PhD, and Conor Lynch, PhD, have been awarded a U01 grant to investigate prostate cancer metastasis.
› Verified 7 days ago
| Entity Name | International Falls Memorial Hospital Association |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1528041183 PECOS PAC ID: 1951365998 Enrollment ID: O20061104000465 |
News Archive
A new drug targeting the PI3K gene in patients with advanced breast cancer shows promising results in an early phase I investigational study conducted at Virginia G. Piper Cancer at Scottsdale Healthcare, according to a presentation by oncologist Dr. Daniel D. Von Hoff at the 47th annual meeting of the American Society of Clinical Oncology.
Scientists have made an important discovery that could lead to new drugs that reduce the severity of blood infections leading to sepsis. Research presented in the August 2010 issue of Journal of Leukocyte Biology shows how interfering with the function of the cell membrane protein called "Programmed Death 1" (PD-1) improves survival in a clinically relevant model of severe infection.
Small molecules found in fecal matter could provide clues to the early inflammation found in chronic gut conditions, such as intestinal bowel disease, and serve as new biomarkers for diagnosis, according to a study led by the Institute for Biomedical Sciences at Georgia State University.
"A critical loophole in the current version of the Senate health-care bill would allow insurers to charge more for those who don't participate in wellness programs, essentially negating the measure's key goal of eliminating higher costs for those with pre-existing conditions, a group of health experts said Thursday," MarketWatch reports.
Moffitt researchers David Basanta, PhD, and Conor Lynch, PhD, have been awarded a U01 grant to investigate prostate cancer metastasis.
› Verified 7 days ago
| Entity Name | Lakewood Health Center |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1922072776 PECOS PAC ID: 5698687929 Enrollment ID: O20080118000179 |
News Archive
A new drug targeting the PI3K gene in patients with advanced breast cancer shows promising results in an early phase I investigational study conducted at Virginia G. Piper Cancer at Scottsdale Healthcare, according to a presentation by oncologist Dr. Daniel D. Von Hoff at the 47th annual meeting of the American Society of Clinical Oncology.
Scientists have made an important discovery that could lead to new drugs that reduce the severity of blood infections leading to sepsis. Research presented in the August 2010 issue of Journal of Leukocyte Biology shows how interfering with the function of the cell membrane protein called "Programmed Death 1" (PD-1) improves survival in a clinically relevant model of severe infection.
Small molecules found in fecal matter could provide clues to the early inflammation found in chronic gut conditions, such as intestinal bowel disease, and serve as new biomarkers for diagnosis, according to a study led by the Institute for Biomedical Sciences at Georgia State University.
"A critical loophole in the current version of the Senate health-care bill would allow insurers to charge more for those who don't participate in wellness programs, essentially negating the measure's key goal of eliminating higher costs for those with pre-existing conditions, a group of health experts said Thursday," MarketWatch reports.
Moffitt researchers David Basanta, PhD, and Conor Lynch, PhD, have been awarded a U01 grant to investigate prostate cancer metastasis.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel J Margo, MD 520 Nw 1st Ave, Ste 5, Grand Rapids, MN 55744-2776 Ph: (218) 327-7973 | Daniel J Margo, MD 1542 Golf Course Rd, Grand Rapids, MN 55744-9603 Ph: (218) 327-7973 |
News Archive
A new drug targeting the PI3K gene in patients with advanced breast cancer shows promising results in an early phase I investigational study conducted at Virginia G. Piper Cancer at Scottsdale Healthcare, according to a presentation by oncologist Dr. Daniel D. Von Hoff at the 47th annual meeting of the American Society of Clinical Oncology.
Scientists have made an important discovery that could lead to new drugs that reduce the severity of blood infections leading to sepsis. Research presented in the August 2010 issue of Journal of Leukocyte Biology shows how interfering with the function of the cell membrane protein called "Programmed Death 1" (PD-1) improves survival in a clinically relevant model of severe infection.
Small molecules found in fecal matter could provide clues to the early inflammation found in chronic gut conditions, such as intestinal bowel disease, and serve as new biomarkers for diagnosis, according to a study led by the Institute for Biomedical Sciences at Georgia State University.
"A critical loophole in the current version of the Senate health-care bill would allow insurers to charge more for those who don't participate in wellness programs, essentially negating the measure's key goal of eliminating higher costs for those with pre-existing conditions, a group of health experts said Thursday," MarketWatch reports.
Moffitt researchers David Basanta, PhD, and Conor Lynch, PhD, have been awarded a U01 grant to investigate prostate cancer metastasis.
› Verified 7 days ago
John A. Kole, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1601 Golf Course Rd, Grand Rapids, MN 55744 Phone: 218-326-5000 | |
Jonathan James Germscheid, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1601 Golf Course Rd, Grand Rapids, MN 55744 Phone: 218-326-3401 | |
Nathan M Noznesky, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1601 Golf Course Rd, Grand Rapids, MN 55744 Phone: 218-326-5000 |